abstract |
The present invention is a peptide ligand of the melanocortin receptor, in particular the melanocortin-4 receptor, and is therefore useful in the treatment of disorders that respond to activation of this receptor, such as obesity, diabetes and sexual dysfunction Related to various ligands. [Selection] Figure 1 |